Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KamRAB vs HRIG for Rabies Post-Exposure Prophylaxis
NCT02040090Phase 3Completed
- Sponsor
- Kamada Ltd.
- Start
- Apr 2013
- Primary completion
- Aug 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of rabies immune globulin (human) in rabies, sponsored by Kamada Ltd.. Started Apr 2013; status: completed.
02
Drugs
rabies immune globulin (human)
03
Conditions
rabies
Beyond the preview
Go deeper on NCT02040090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040090.